The MarketWatch News Department was not involved in the creation of this content. COLUMBIA, S.C., April 01, 2026 (GLOBE NEWSWIRE) -- Integer Technologies, a leading provider of adaptive artificial ...

(MENAFN- GlobeNewsWire - Nasdaq) Company outlines near-term pharmacokinetic milestones, highlights amorphous formulation strategy, and announces planned global patent filing TAMPA, Fla., March 31, ...

COLUMBIA, S.C., April 01, 2026 (GLOBE NEWSWIRE) -- Integer Technologies, a leading provider of adaptive artificial intelligence (AI) defense technologies for cyber-physical resilience, today announced ...

TAMPA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. (OTCQB: INTI) ("Inhibitor" or the "Company"), today provided an update on its ongoing pharmacokinetic (PK) clinical program ...

Energy efficiency is a critical challenge in Beyond-5G (B5G) cellular networks, where ground base stations (GBSs) are responsible for a substantial portion of network energy consumption. Reducing this ...

NFL season matchups are determined by a rotating schedule of cross-division opponents combined with each team’s in-division ranking from the previous season. Playwright was used to scrape the official ...

Abstract: The Distribution Network Reconfiguration (DNR) problem is a well-known problem in the field of power system optimization. It consists of altering the state of the switches in Distribution ...

This repository contains code relating to the paper "A Combinatorial Branch-and-Bound Algorithm for the Capacitated Facility Location Problem under Strict Customer Preferences" by Christina Büsing, ...

Oral ANAVEX ® 3-71 tablet exhibits superior pharmacokinetics compared to the current immediate-release oral capsule, enabling once-daily dosing NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Anavex Life ...

Breaking the Binary Theatre has revealed programming for the fourth annual Breaking the Binary Theatre Festival. The festival, which will continue the groundbreaking theater company’s mission of ...

VANCOUVER, BC / ACCESS Newswire / July 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...